您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Chicoric acid
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Chicoric acid
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Chicoric acid图片
CAS NO:6537-80-0
包装与价格:
包装价格(元)
10 mM * 1 mL in Water电议
10mg电议
25mg电议
50mg电议
100mg电议
200mg电议

产品名称
菊苣酸
Cichoric Acid
Dicaffeoyltartaric acid
产品介绍
Chicoric acid (Cichoric acid) 是一种口服有效的二咖啡基酒石酸,可以诱导活性氧 (ROS) 的产生。Chicoric acid 抑制细胞活力,并通过 ROS 介导的 PI3K/Akt 和 MAPK 信号通路诱导 3T3-L1 前脂肪细胞中的线粒体依赖性细胞凋亡。Chicoric acid 增加葡萄糖摄取,改善胰岛素抵抗,并减轻氨基葡萄糖诱导的炎症。Chicoric acid 具有抗糖尿病和抗氧化、抗炎作用。
生物活性

Chicoric acid (Cichoric acid), an orally active dicaffeyltartaric acid, inducesreactive oxygen species(ROS)generation. Chicoric acid inhibits cell viability and induces mitochondria-dependentapoptosisin 3T3-L1 preadipocytes through ROS-mediated PI3K/Akt and MAPK signaling pathways. Chicoric acid increases glucose uptake, improvesinsulinresistance, and attenuates glucosamine-induced inflammation. Chicoric acid has antidiabetic properties and antioxidant, anti-inflammatory effects[1][2][3].

体外研究
(In Vitro)

Chicoric acid (Cichoric acid; 10-200 μM; for 24, 48, and 72 h) causes a dose- and time-dependent decrease in cell viability[1].
Chicoric acid (100 μM; 48 h) induces apoptosis through caspase-3-dependent pathway[1].
Chicoric acid (100 μM; 48 h) decreases the protein level of p-Akt[1].
Chicoric acid (25, 50, 100 μM; for 24 hours) dramatically improves glucose uptake in a dose-dependent manner, and Chicoric acid further enhances insulin-induced (100 nM; 30 min) glucose uptake by 57.7% in HepG2 cells[2].
Chicoric acid (100 μM; for 24 hours) restores glucosamine-induced impairment of GLUT2 translocation through activating PI3K/Akt pathway in HepG2 cells[2].
Chicoric acid (100 μM) has no effects on HepG2 cell viability[2].

Cell Viability Assay[1]

Cell Line:3T3-L1 preadipocytes
Concentration:10-200 μM
Incubation Time:24, 48, and 72 hours
Result:Had no effect on the viability of 3T3-L1 preadipocytes with 10-50 μM for 24 h, but significantly decreased cell viability with 100 μM and 200 μM.

Apoptosis Analysis[1]

Cell Line:3T3-L1 preadipocytes
Concentration:100 μM
Incubation Time:48 hours
Result:Demonstrated typical characteristics of apoptosis such as cell shrinkage, chromatin condensation, and the increased permeability of cell membranes after DAPI and AO/EB staining.

Western Blot Analysis[1]

Cell Line:3T3-L1 preadipocytes
Concentration:100 μM
Incubation Time:48 hours
Result:Decreased the protein level of p-Akt in a dose- and time-dependent manner.
The protein level of total Akt was not affected
体内研究
(In Vivo)

Chicoric acid (Cichoric acid; 60 mg/kg/day; drinking water for 4 weeks) inhibits pancreas apoptosis and adjusts islet function in diabetic mice, leading to an increase in insulin generation and secretion in C57BL/6J mice with Streptozotocin (STZ; 50 mg/kg; ip; for consecutive 5 days)[3].

Animal Model:C57BL/6J mice with STZ (50 mg/kg; ip; for consecutive 5 days)[3]
Dosage:60 mg/kg
Administration:Drinking water; daily; for 4 weeks
Result:Inhibited pancreas apoptosis and adjusted islet function in diabetic mice, leading to an increase in insulin generation and secretion.
Regulated mitochondrial biogenesis, glycogen synthesis, and inhibited inflammation via activating antioxidant responses.
Showed a remarkable increase in body weight starting at week 7.
分子量

474.37

性状

Solid

Formula

C22H18O12

CAS 号

6537-80-0

中文名称

菊苣酸

结构分类
  • Phenylpropanoids
  • Other Phenylpropanoids
  • Phenols
  • Polyphenols
来源
  • Plants
  • other families
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder-20°C3 years
4°C2 years
In solvent-80°C6 months
-20°C1 month
溶解性数据
In Vitro: 

H2O : 100 mg/mL(210.81 mM;Need ultrasonic)

DMSO : 1 mg/mL(2.11 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM2.1081 mL10.5403 mL21.0806 mL
5 mM0.4216 mL2.1081 mL4.2161 mL
10 mM0.2108 mL1.0540 mL2.1081 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: PBS

    Solubility: 50 mg/mL (105.40 mM); Clear solution; Need ultrasonic

*以上所有助溶剂都可在本网站选购。